We do have Covid19 IgG/IgM Immunoassay rapid tests to fight the pandemic
0

Your Cart is Empty

Including pregnant women in vaccine research

January 23, 2019

Including pregnant women in vaccine research

Last month, the Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies ( PREVENT) Working Group released a long overdue report on the issue of including pregnant women in vaccine research. The report comes after the World Health Organization’s (WHO) vaccine advisory group said it was not recommending Ebola vaccination for pregnant women or women who are lactating in the current outbreak in the Democratic Republic of Congo (DRC), when a new vaccine was delivered in the worst affected areas. The vaccine is a live vaccine, which is not normally given to pregnant women.

The safety evidence of the Ebola vaccine in pregnant women is unclear. However, what is clear is that approximately 90% of pregnant women who are infected with Ebola die from the disease and nearly 100% of pregnancies in Ebola infected women end in miscarriage or neonatal death. These numbers clearly show that preventing Ebola in pregnant women during an acute outbreak is vital when the outcomes are so severe. When the risk of mortality is so high, the benefits of offering the vaccine outweighs the risks. Denying pregnant women vaccination highlights yet again the unequal emphasis placed on the life of the woman carrying the pregnancy. In general, clinical guidelines state that the life of the mother should be prioritized over the fetus when mother and fetus are in danger. As Ebola has such a high mortality rate, simply not giving the vaccine to pregnant women because of a fear of affecting the unborn fetus, places more importance on the life of the fetus than the mother.

The problem seen in the Ebola outbreak in the DRC is not unique. Pregnant women tend to be excluded from vaccine research to protect them from risks. However, by doing so, a vicious cycle is created whereby pregnant women are excluded from studies meaning evidence cannot be generated, which further excludes them from vaccinations during outbreaks. The fear of adverse effects towards the fetus and mother is sometimes not based on evidence and this can create more harm.

The PREVENT group has brought together experts in the ethics, obstetrics, pediatrics, public health and vaccine research field to help tackle this evidence gap. Their report includes 22 recommendations which are centered around the importance of offering vaccines to pregnant women during epidemics (this should be the default), the inclusion of pregnancy status in real world studies (for e.g. it is likely that during the Ebola outbreak, pregnancy status would not have been determined in women who were obviously not pregnant at the time of vaccination. Therefore, there would have been women who were pregnant who received the vaccine and were not followed up), assessment of risks and benefits, the expert opinion of maternal fetal experts in the inclusion and exclusion of pregnant women in studies, and the perspectives of pregnant women themselves to guide vaccine research.

There is a positive shift to include pregnant women in clinical trials, but the progress is slow. Research and academic communities are only just realizing the importance of disaggregating data by sex and including women in clinical trials – finally acknowledging that conditions and drugs affect women differently to men. Hopefully, this new report will push the research community towards creating an evidence base for those who are pregnant and for women as a whole.

 

Photo credit: NIH


Leave a comment

Comments will be approved before showing up.


Also in The Maternova blog

Killing Two Birds With One Stone: Addressing Malnutrition and Lack of Clean Water
Killing Two Birds With One Stone: Addressing Malnutrition and Lack of Clean Water

June 24, 2020

Access to both adequate, nutritional food and clean drinking water is necessary to ensure the health of our world’s children - one without the other is insufficient.
Read More
Improvement as Innovation: Rice-Based Oral Rehydration Solutions
Improvement as Innovation: Rice-Based Oral Rehydration Solutions

June 08, 2020

Almost 1.6 million people died from diarrheal diseases in 2017.  1.6 million individuals.  And one-third of them were children under five (1).  Diarrheal disease, which is predominantly caused by contaminated food and water, strips the body of the water and salts necessary for normal function, resulting in the severe dehydration and fluid loss that are responsible for most diarrhea deaths (2). The cause of the disease may be viral, bacterial, or parasitic.

Read More
Why the focus on Covid19 serology testing and what does it mean?
Why the focus on Covid19 serology testing and what does it mean?

April 20, 2020

By contrast, the  immunoassay IgG/IgM test  is a rapid point of care blood (or serology) test that is best suited for determining whether someone has, in the recent past, been exposed to, and mounted an immune response to the Covid19 infection. This test is made by immobilizing the antigen,
Read More
News & Updates

Sign up to get the latest on sales, new releases and more …

maternal and newborn health news